SG3 Management, LLC

SEC CIK: 0001630888
Latest filing: Nov 15, 2023

SEC filings (opens in a new tab)

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by SG3 Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overview All 13F holders of ESPR Full Q3 2023 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of ESPR by SG3 Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−6,000−100.0%	Sold out	Holders
Q4 2022	6,000	$37.4K	<0.1%	+6,000	New	Holders
Q3 2021	0	$0	0.0%	−4,000−100.0%	Sold out	Holders
Q2 2021	4,000	$85.0K	<0.1%	+4,000	New	Holders